Qiagen receives EUA for portable SARS-CoV-2 antigen test

LabPulse.com staff writers
Aug 5, 2021
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400

Qiagen announced it has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for its QIAreach SARS-CoV-2 Antigen Test, a rapid portable test that the company said can analyze over 30 samples per hour for the SARS-CoV-2 antigen.

The company touted its test, developed in collaboration with Ellume, as providing digital results in two to 15 minutes. It also uses Qiagen's Underwriters Laboratories (UL)-certified eHub, a portable reader with backup battery power that can be operated remotely from the main power for up to eight hours.

Latest in Infectious
Bacteria Mycobacterium Tuberculosis Social
Danaher cuts cost of rapid TB test after years of pressure from activists
September 21, 2023
Research Money Social
Day Zero Diagnostics completes $16M financing round
September 20, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Lab Blood Tubes Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
September 18, 2023
Related Stories
2022 07 15 19 23 6017 White House 400
510(k)
Ellume COVID-19 test available at no cost to the blind
2021 11 08 22 23 6155 Settlement 400
PCR
Qiagen and BD settle PCR patent lawsuit
2019 12 03 00 00 5470 Tuberculosis Lungs 400
Tuberculosis
Qiagen launches new tuberculosis test
At-home or Lab-based STI testing/collection
Sponsor Content
At-home or Lab-based STI testing/collection
More in Infectious
Danaher cuts cost of rapid TB test after years of pressure from activists
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Bacteria Mycobacterium Tuberculosis Social
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Lab Blood Tubes Social
Moderna’s mRNA flu shot yields promising results in phase III trial
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
USP proposes synthetic alternative to horseshoe crab blood in endotoxin testing
The U.S. Pharmacopoeia (USP) has published draft guidelines on using a synthetic alternative to reagents derived from horseshoe crabs, advancing efforts to provide an alternative way of performing endotoxin testing.
August 31, 2023
Lab Blood Man Social
Gene expression test may improve diagnosis of febrile childhood diseases
A simple blood test based on patterns of gene expression could radically improve and speed up the diagnosis of febrile childhood diseases, say researchers.
August 30, 2023
Child Hospital Social
Raman spectroscopy slashes time to detect pathogens bound to magnetic beads
Raman spectroscopy can accelerate the detection of pathogens bound to microscopic magnetic beads, according to a paper that will be published in the Journal of Raman Spectroscopy.
August 28, 2023
Dynabeads, which are antibody-coated superparamagnetic beads, served as a strong Raman reporter for the simultaneous capture and detection of pathogenic bacterium such as Salmonella enterica. This image shows the Dynabeads (gray spheres) interacting with S. enterica bacterium (in green). The inset shows the Y-shaped antibodies coating the Dynabeads.
Nonprofit health system adopts Immunexpress test for detecting sepsis
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
NIH names Jeanne Marrazzo to fill NIAID post vacated by Anthony Fauci
Marrazzo currently works as director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is expected to take up her position as the director of the NIAID in the fall.
August 3, 2023
Nih Logo Social
PBD receives U.S. patent for phage-based tuberculosis diagnostic kit
PBD is using its expertise in phages to develop Actiphage, a test designed to detect the active mycobacteria that cause tuberculosis in blood samples.
August 1, 2023
Bacteriophage Social
Proliferation of infectious disease tests leading to misuse and misinterpretation: Report
The disconnect between changes in demand and capabilities can result in lab directors being asked to oversee testing that is outside of their areas of expertise. Additionally, there are more and more testing options.
July 28, 2023
Lab Test Antibody Social
Page 1 of 147
Next Page